HeXun Biosciences Co., Ltd. (TPEX:6986)

Taiwan · Delayed Price · Currency is TWD

43.95

+0.30 (0.69%)

Jul 30, 2026, 12:49 PM CST

HeXun Biosciences Financials Overview

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	293.23	293.23	286.42	130.57	49.47	-
Revenue Growth	2.38%	2.38%	119.36%	163.94%	-	-
Gross Profit	266.28	266.28	260.67	113.73	44.61	-
Operating Income	118.01	118.01	155.73	27.37	-8.98	-50.66
Net Income	111.91	111.91	147.22	33.49	-5.19	-42.99
Earnings Per Share	2.43	2.43	3.20	0.74	-0.14	-1.41
EPS Growth	-24.06%	-24.06%	332.90%	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Taiwan	282.49	282.49	286.42	130.57	49.47
Other	10.74	10.74	-	-	-
Total	293.23	293.23	286.42	130.57	49.47

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	509.63	509.63	372.99	329.67	191.74	85.03
Total Debt	36.58	36.58	35.02	72.61	71.64	74.1
Net Cash (Debt)	473.05	473.05	337.97	257.06	120.11	10.93
Net Cash Growth	39.97%	39.97%	31.47%	114.03%	999.17%	-
Net Cash Per Share	10.28	10.28	7.34	5.67	3.20	0.36

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	163.89	163.89	120.92	43.09	11.23	-35.5
Capital Expenditures	-27.29	-27.29	-37.29	-20.67	-1.23	-
Free Cash Flow	136.61	136.61	83.63	22.42	10	-35.5
Free Cash Flow Growth	63.36%	63.36%	272.98%	124.19%	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	90.81%	90.81%	91.01%	87.10%	90.18%	-
Operating Margin	40.24%	40.24%	54.37%	20.96%	-18.15%	-
Pretax Margin	42.95%	42.95%	56.38%	25.65%	-10.49%	-
Profit Margin	38.16%	38.16%	51.40%	25.65%	-10.49%	-
FCF Margin	46.59%	46.59%	29.20%	17.17%	20.22%	-

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	18.09	25.90	21.09	89.01	-	-
P/FCF Ratio	14.80	21.21	37.13	132.95	-	-
PS Ratio	6.89	9.88	10.84	22.83	-	-